BPC-157 + TB-500 Peptide Blend for Recovery + Mobility Support
A clinician-guided peptide blend designed to support the body’s recovery response, day-to-day comfort, and mobility goals—with provider oversight, clear pricing, and discreet delivery
This is a prescription-based peptide therapy provided only if a licensed clinician determines it is appropriate based on your medical history, goals, and current medications. Use only as prescribed. Individual results vary.
Licensed clinician review + safety screening
Pharmacy fulfillment + discreet shipping
Transparent 4-week pricing (no subscription required)
Available in eligible states.
Choose your BP-157/TB500 plan
- Dosage Description
- 100/100mcg BPC-157/TB500 SQ daily for 4 Weeks
- Dose
- 100
- Duration
- 4 Week
- Package Size
- 5
- Form
- Injection
- Dosage Description
- 150/150mcg BPC-157/TB500 SQ daily for 4 Weeks
- Dose
- 150
- Duration
- 4 Week
- Package Size
- 5
- Form
- Injection
- Dosage Description
- 200/200mcg BPC-157/TB500 SQ daily for 4 Weeks
- Dose
- 200
- Duration
- 4 Week
- Package Size
- 5
- Form
- Injection
- Dosage Description
- 250/250mcg BPC-157/TB500 SQ daily for 4 Weeks
- Dose
- 250
- Duration
- 4 Week
- Package Size
- 5
- Form
- Injection
- Dosage Description
- 300/300mcg BPC-157/TB500 SQ daily for 4 Weeks
- Dose
- 300
- Duration
- 4 Week
- Package Size
- 5
- Form
- Injection
What is the BP-157/TB500 blend?
BP-157/TB500 is a clinician-guided blend that combines two peptides often discussed in recovery-focused wellness settings:
BPC-157: a synthetic peptide studied primarily in preclinical models for tissue and gut pathway support.
TB-500: (often described as a thymosin beta-4 fragment): a peptide discussed for broader recovery-support pathways in preclinical research.
This blend is commonly chosen by people who want a structured, provider-screened approach to recovery and mobility goals—without exaggerated promises.
Who the BP-157/TB500 blend may be best for
This blend may be considered for adults who:
- Feel “beat up” from training, repetitive motion, or physically demanding work
- Want recovery and mobility support as part of a broader plan
- Are working through a structured rehab or movement program and want clinician-guided support
- Prefer clear 4-week pricing and discreet delivery
Who may not be a candidate
Your clinician may advise against this option (or require additional review) if you:
- Are pregnant, trying to become pregnant, or breastfeeding
- Have a history of cancer or an active/unexplained mass (requires careful clinician review)
- Have autoimmune or immune-system conditions that increase risk of immune reactions (clinician review required)
- Have significant liver or kidney disease (clinician review required)
- Have an active infection, unexplained fever, or significant systemic symptoms
- Have a known allergy to peptide products or formulation components
- Compete in tested sports (these peptides may be prohibited under anti-doping rules)
What you get with StemVera’s BP-157/TB500 program
Included:
- Secure online intake (goals, symptoms, medical history, medications, allergies)
- Licensed clinician review to confirm eligibility and safety
- Prescription only if appropriate
- Pharmacy fulfillment + discreet delivery
- Supplies included as needed for administration
- Ongoing check-ins via secure messaging for questions and tolerance support
How to start the BP-157/TB500 blend
- 1
Complete your intake
Share your recovery goals, what feels limited (mobility, comfort, training consistency), and your full medical history.
- 2
Clinician review
A licensed clinician evaluates fit, screens for risks, and confirms whether this option is appropriate.
- 3
Discreet delivery
If prescribed, your plan ships discreetly with tracking.
- 4
Ongoing support
Message your care team if you have side effects, questions, or a change in health status.
Injection basics (what to expect)
No dosing, timing, titration, or usage instructions here—follow your prescription label and clinician guidance exactly. Use only as prescribed.
- Often administered as a subcutaneous (under-the-skin) injection when prescribed
- Mild injection-site redness, soreness, or bruising can occur
- Use sterile technique and dispose of supplies safely
- Do not share medication or supplies
- If anything is unclear, message your care team before your next dose
Timeline: what to realistically expect
Recovery-focused therapies are usually evaluated over weeks—not days.
- What some people report (varies):
- Early: subtle changes in “recovery readiness” or day-to-day comfort
- Over time: improved consistency with training or movement routines
- Best outcomes: when paired with sleep, hydration, nutrition, mobility work, and smart training load
- Results vary widely. No peptide therapy can guarantee injury recovery, performance changes, or a specific outcome.
Possible side effects
Common (often mild)
- Injection-site redness, swelling, tenderness, or itching
- Headache
- Nausea or stomach discomfort
- Fatigue or lightheadedness
Less common but serious (seek medical help)
- Signs of allergic reaction (hives, facial swelling, trouble breathing)
- Injection-site infection (worsening redness, warmth, pus, fever)
- Severe or persistent abdominal pain, chest pain, fainting
- New or rapidly worsening symptoms
If side effects feel severe, sudden, or persistent, stop and contact your care team promptly.
Safety + important warnings
- This blend is not appropriate for everyone. Your clinician will screen your history and medications before prescribing.
- Important considerations:
- Limited human data: safety and effectiveness information in humans is limited, and long-term risks are not well defined
- Immunogenicity/impurity risk: peptide therapies can carry risks related to immune reactions and product impurities; report rash, swelling, breathing difficulty, or systemic symptoms promptly
- Quality matters: avoid unverified sources; contamination and mislabeling are known concerns in the peptide marketplace
- Athletes: if you compete in tested sports, confirm anti-doping status before starting
- Use only as prescribed; do not share medication
- Compounded products are not FDA-approved and do not undergo FDA premarket review for safety, effectiveness, or quality. Peptide therapy may be prescribed for off-label use; results vary.
Compare related recovery support options
BPC-157 (Single Peptide)
A single-peptide option for recovery and mobility support goals (provider-directed).
BPC-157 Acetate Capsule
Oral option for eligible patients who prefer a non-injection format (provider-directed).
BPC-157/KPV/TB500
Blend option sometimes selected for combined recovery + gut pathway support goals (provider-directed).